Literature DB >> 18631016

Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.

Doru T Alexandrescu, Geanina Popoveniuc, Haleh Farzanmehr, Constantin A Dasanu, Nancy Dawson, Leonard Wartofsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18631016     DOI： 10.1089/thy.2007.0349

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  4 in total

Review 1.  Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management.

Authors:  Rebecca L Brown
Journal:  Target Oncol       Date:  2011-11-19       Impact factor: 4.493

Review 2.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

3.  Sunitinib-induced thyrotoxicosis.

Authors:  D Piñar; E Boix; J A Meana; J Herrero
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

4.  Cabozantinib-induced thyroid dysfunction: a review of two ongoing trials for metastatic bladder cancer and sarcoma.

Authors:  Sahzene Yavuz; Andrea B Apolo; Shivaani Kummar; Jaydira del Rivero; Ravi A Madan; Thomas Shawker; James Reynolds; Francesco S Celi
Journal:  Thyroid       Date:  2014-06-05       Impact factor: 6.568
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.